A share price of Gilead Sciences, Inc [GILD] is currently trading at $114.54, up 1.15%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The GILD shares have gain 2.72% over the last week, with a monthly amount glided 1.36%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Oppenheimer reaffirmed its Outperform rating on March 04, 2025, and elevated its price target to $132. On February 18, 2025, upgrade upgraded it’s rating to Buy but maintained its price target of $120 on the stock. DZ Bank upgraded its rating to a Buy but stick to its price target of $108 on February 13, 2025. Morgan Stanley upgraded its rating to a Overweight and raised its price target to $113 on January 10, 2025. In a note dated November 15, 2024, Wolfe Research initiated an Outperform rating and provided a target price of $110 on this stock.
Gilead Sciences, Inc experienced fluctuations in its stock price throughout the past year between $67.65 and $119.96. Currently, Wall Street analysts expect the stock to reach $129.5 within the next 12 months. Gilead Sciences, Inc [NASDAQ: GILD] shares were valued at $114.54 at the most recent close of the market. An investor can expect a potential return of 13.06% based on the average GILD price forecast.
Analyzing the GILD fundamentals
Trailing Twelve Months sales for Gilead Sciences, Inc [NASDAQ:GILD] were 28.69B which represents -0.60% decline. Gross Profit Margin for this corporation currently stands at 0.78% with Operating Profit Margin at 0.29%, Pretax Profit Margin comes in at 0.24%, and Net Profit Margin reading is 0.21%. To continue investigating profitability, this company’s Return on Assets is posted at 0.11, Equity is 0.32 and Total Capital is 0.19. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of1.3.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 113.29 points at the first support level, and at 112.04 for the second support level. However, for the 1st resistance point, the stock is sitting at 115.33, and for the 2nd resistance point, it is at 116.12.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Gilead Sciences, Inc [NASDAQ:GILD] is 1.37. As well, the Quick Ratio is 1.23, while the Cash Ratio is 0.64. Considering the valuation of this stock, the price to sales ratio is 4.97, the price to book ratio is 7.44 and price to earnings (TTM) ratio is 24.08.
Transactions by insiders
Recent insider trading involved O’Day Daniel Patrick, Chairman & CEO, that happened on Jun 30 ’25 when 10000.0 shares were sold. Officer, DANIEL O’DAY completed a deal on Jun 30 ’25 to buy 10000.0 shares. Meanwhile, Chief Financial Officer Dickinson Andrew D sold 2500.0 shares on Jun 16 ’25.
